Breaking News

You are here » Indian-Commodity  :  Corporate  :  United Bank of India reports net loss of Rs 388.68 crore in Q1

10-Aug2018

United Bank of India reports net loss of Rs 388.68 crore in Q1

United Bank of India has reported results for first quarter ended June 30, 2018.

The Bank has reported a net loss of Rs 388.68 crore for the quarter under review as compared to net loss of Rs 211.46 crore for the same quarter in the previous year. Total income of the Bank decreased by 10.62% at Rs 2,549.71 crore for Q1FY19 as compared Rs 2,852.61 crore for the corresponding quarter previous year.

The Bank's gross NPA for the April-June quarter of the current fiscal increased to 22.73%, as compared to 17.17% in the same quarter of the previous year. Besides, Bank's Net NPA stood at 15.17% in Q1FY19.


Related News

View all news

MRF's workers call strike at Tiruvottiyur plant

MRF's workers are on strike at manufacturing plant at Tiruvottiyur near Chennai, since February 2. The strike is illegal and the notice of the strike, including reasons for the same, has not been served......

Linde India reports 62% rise in Q4 net profit

Linde India has reported results for fourth quarter ended December 31, 2018. The company has reported a rise of 61.97% in its net profit at Rs 15.42 crore for the quarter under review as compared to Rs......

Valecha Engineering reports net loss of Rs 15.98 in Q3

Valecha Engineering has reported results for third quarter ended December 31, 2018. The company has reported a net loss of Rs 15.98 crore for the quarter as compared to net loss of Rs 13.19 crore for the......

Top News

View all news

Tata Motors signs LTS agreement with its employees

Tata Motors has signed a long-term wage settlement (LTS) agreement with its employees. Under the agreement, workmen will get a wage rise of Rs 9,000 per month along with other incentives based on performance.......

Canara Bank invites bids from merchant bankers to manage its $350-500 million MTN issue: Report

Canara Bank has reportedly invited bids from merchant bankers to manage its $350-500 million issue of senior unsecured/tier-II capital bonds under its medium-term note (MTN) programme. The issue size may......

Alembic Pharma gets USFDA's nod for Acetazolamide Extended-Release Capsules

Alembic Pharmaceuticals (Alembic) has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Acetazolamide Extended-Release Capsules, 500......